Case Report: Persistent COVID-19 in a fully vaccinated Japanese man being treated with rituximab and epcoritamab for diffuse large B-cell lymphoma

Case Report: Persistent COVID-19 in a fully vaccinated Japanese man being treated with rituximab and epcoritamab for diffuse large B-cell lymphoma

The management of persistent coronavirus disease 2019 (COVID-19) in patients with hematological malignancies who are immunocompromised because of underlying disease or iatrogenic immunosuppression remains clinically challenging. Herein, we report an 84-year-old man with stage 3 diffuse large B-cell...

Full description

Saved in:
Bibliographic Details
Main Authors: Masaki Suzuki, Isao Fujioka, Takamitsu Matsushima
Format: Article
Language:English
Published: Frontiers Media S.A. 2025-04-01
Series:Frontiers in Medicine
Subjects:
persistent COVID-19
diffuse large B-cell lymphoma
rituximab
epcoritamab
SARS-CoV-2
Online Access:https://www.frontiersin.org/articles/10.3389/fmed.2025.1554100/full
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items